AMTZ is India’s premier medical technology park with Common Manufacturing Facilities & Common Scientific Facilities that include specialized laboratories, warehousing, and testing centers such as the Center for Electromagnetic Compatibility and Safety Testing, Center for Biomaterial Testing, Center for 3-D Printing, Centers for Lasers, MRI Superconducting Magnets, Gamma Irradiation Centre, Mold & Machining Centre, and many other industrial service centers.
Dr. Rajiv Bahal, Director General, Indian council for Medical Research (ICMR) & Dr. Jitendra Sharma, MD & CEO AMTZ, inaugurated ACCUREX’s Blood Glucose Monitoring POCT Device manufacturing facility at AMTZ.
Dr. Rajiv Bahal expressed his best wishes for taking forward the Make In India initiative taken by Accurex to make glucometers affordable and accessible to the economically weaker sections of our society.
We at Accurex are planning to work towards non-invasive continuous glucose systems (CGMS) and HbA1c POCT devices to help the diabetic population to monitor and control their diabetes for a healthier India!
*This press release is published by VOH team.*
Psoriasis drug launch marks Eli Lilly’s entry into dermatology domain
SAMRIDH Healthcare invests in Critical Care Hope to catalyze tele-ICUs across th
Health Check on Wheels: Apollo Hospitals Launches Gujarat’s First Fully-equipp
Steven Mou to steer Mindray’s ‘India Mission’ as Managing Director
Making Robotics Mainstream: HCG Hospitals Collaborates with Us-Based Intuitive t
Dr. Rajeev Singh Raghuvanshi appointed Drugs Controller General of India
Accurex BGMS (Blood Glucose Monitoring System) Factory Inauguration at Andhra Pr
VOH: Incubator Driving Innovation and Improving Access to Healthcare in India
Augnito Launches Its Developer Portal To Abridge Integration Timelines
MediBuddy acquires ‘vHealth by Aetna’, the India health business of Aetna In
Ayurveda in MBBS Curriculum?
The First Active Bone Conduction Implant (Bone Bridge - BCI-602) in India was do
UPSC recommends Rajeev Singh Raghuvanshi as next DCGI
Mankind Pharma invests in Actimed Therapeutics, a UK based clinical stage specia
Tata Capital Healthcare Fund infuses $ 10 mn in Mumbai Oncocare CentreView All